These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 844915)

  • 1. HLA in familial Hodgkin's disease. Results and a new hypothesis;
    Marshall WH; Barnard JM; Buehler SK; Crumley J; Larsen B
    Int J Cancer; 1977 Apr; 19(4):450-5. PubMed ID: 844915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA haplotypes in a genetic isolate in Newfoundland. A population showing 8% homozygosity and a familial aggregate of lymphoma and immunodeficiency cases.
    Larsen B; Barnard JM; Buehler SK; Marshall WH
    Tissue Antigens; 1976 Sep; 8(3):207-15. PubMed ID: 973211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA in familial Hodgkin's disease.
    Conte R; Lauria F; Zucchelli P
    J Immunogenet; 1983 Jun; 10(3):251-5. PubMed ID: 6875280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hodgkin's disease susceptibility: linkage to the HLA locus demonstrated by a new concordance method.
    Berberich FR; Berberich MS; King MC; Engleman EG; Grumet FC
    Hum Immunol; 1983 Apr; 6(4):207-17. PubMed ID: 6221004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA and susceptibility to Hodgkin's disease.
    Hors J; Dausset J
    Immunol Rev; 1983; 70():167-92. PubMed ID: 6403456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of histocompatibility haplotype HLA-A3-B7 with multiple sclerosis.
    Bertrams HJ; Kuwert EK
    J Immunol; 1976 Nov; 117(5 Pt.2):1906-12. PubMed ID: 993587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypocomplementaemic and normocomplementaemic multiple sclerosis. Genetic determinism and association with specific HLA determinants (B18 and B7).
    Trouillas P; Betuel H
    J Neurol Sci; 1977 Jul; 32(3):425-35. PubMed ID: 886365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hodgkin's disease presenting in 1 of 4 siblings affected by hereditary spinocerebellar ataxia: clinical, immunological and genetic study.
    Mantovani G; Coiana A; Sanna GP; Farci G; Cabras F; Arangino V; Orrù S; Leone AL; Vacca A; Balestrieri A
    Eur Neurol; 1989; 29(3):156-63. PubMed ID: 2786467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pedigree analysis of Hodgkin's disease in a Newfoundland genealogy.
    Thompson EA
    Ann Hum Genet; 1981 Jul; 45(3):279-92. PubMed ID: 7305282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inheritance of asthma in families and its linkage to HLA haplotypes.
    Wagatsuma Y; Yakura H; Nakayama E; Wakisaka A; Aizawa M
    Acta Allergol; 1976 Dec; 31(6):455-62. PubMed ID: 1037060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA antigens in Hodgkin's disease of very long survival.
    Hornmark-Stenstam B; Landberg T; Löw B
    Acta Radiol Oncol Radiat Phys Biol; 1978; 17(4):283-8. PubMed ID: 717041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial Hodgkin's disease and the major histocompatibility complex.
    Bowers TK; Moldow CF; Bloomfield CD; Yunis EJ
    Vox Sang; 1977; 33(5):273-7. PubMed ID: 144365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial Hodgkin's disease. A clinical and laboratory investigation.
    Robertson SJ; Lowman JT; Grufferman S; Kostyu D; van der Horst CM; Matthews TJ; Borowitz MJ; Bigner SH
    Cancer; 1987 Apr; 59(7):1314-9. PubMed ID: 3028599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of HLA-A*02 antigen status in Hodgkin's disease and analysis of an HLA-A*02-restricted epitope of the Epstein-Barr virus LMP-2 protein.
    Bryden H; MacKenzie J; Andrew L; Alexander FE; Angus B; Krajewski AS; Armstrong AA; Gray D; Cartwright RA; Kane E; Wright DH; Taylor P; Jarrett RF
    Int J Cancer; 1997 Aug; 72(4):614-8. PubMed ID: 9259400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial Hodgkin's lymphoma from the perspective of HLA.
    Sonmez M; Erkut N; Ucar F; Buruk K; Cobanoglu U; Bahce M; Ural AU
    Intern Med; 2010; 49(6):607-10. PubMed ID: 20228601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bf types of HLA haplotyped individuals in an isolated Newfoundland population.
    Larsen B; Arnason A; Barnard JM; Buehler SK; Edwards JH; Marshall WH
    Tissue Antigens; 1977 Nov; 10(5):403-9. PubMed ID: 75584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Etiological heterogeneity in Hodgkin's disease: HLA linked and unlinked determinants of susceptibility independent of histological concordance.
    Chakravarti A; Halloran SL; Bale SJ; Tucker MA
    Genet Epidemiol; 1986; 3(6):407-15. PubMed ID: 3803911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association with HLA class I in Epstein-Barr-virus-positive and with HLA class III in Epstein-Barr-virus-negative Hodgkin's lymphoma.
    Diepstra A; Niens M; Vellenga E; van Imhoff GW; Nolte IM; Schaapveld M; van der Steege G; van den Berg A; Kibbelaar RE; te Meerman GJ; Poppema S
    Lancet; 2005 Jun 25-Jul 1; 365(9478):2216-24. PubMed ID: 15978930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA/Bf haplotypes in a Newfoundland family.
    Larsen B; Pepper B; Barnard JM; Farid NR
    Tissue Antigens; 1978 Jul; 12(1):39-43. PubMed ID: 581240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Relation of HLA antigens to prognosis in Hodgkin's disease].
    Prazák J; Chytrý P; Hermanská Z
    Vnitr Lek; 1991; 37(9-10):781-8. PubMed ID: 1771812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.